Skip to main content

Ryan Schubert, MD

Head of Translational Medicine at Asceneuron S.A.

Location: San Francisco, CA United States

Ryan Schubert is currently the Senior Director in Clinical Development and Head of Translational Medicine at Asceneuron. During his academic training at Stanford and UCSF, Ryan developed novel biomarkers and approaches to identify the targets and triggers of neuroinflammatory diseases like multiple sclerosis and acute flaccid myelitis. Ryan is passionate about scientific discoveries that can be transformed into innovative drug companies, so that patients with unmet needs benefit from the latest advances in research. At Asceneuron, Ryan is responsible for implementing biomarkers in the company’s clinical trials and is a key member of the clinical team bringing Asceneuron’s lead compounds to patients with neurodegenerative diseases.

Associated Grants

  • Assessment of Alpha-synuclein Aggregation Inhibitor ASN121151 as a Potential New Treatment for Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.